We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory committee recommended approval of Sanofi’s combination candidate for Type 2 diabetes Wednesday, making it the second such product backed by the committee in the last 24 hours. Read More
Industry groups are worried that a section of the proposed FDA and NIH Workforce Authorities Modernization Act would exempt biologics from adhering to U.S. Pharmacopeial standards for quality. Read More